DOUG vs IPHA
Comparison between Douglas Elliman Inc (DOUG, Company) and Innate Pharma (IPHA, Company).
DOUG is from the Real Estate sector, while IPHA is from the Healthcare sector.
5-Year PerformanceIPHA has outperformed DOUG, delivering a return of -11.6% compared to -32.2%
DOUG vs IPHA - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
DOUG vs IPHA - Historical Returns
Returns include dividend reinvestment.
DOUG vs IPHA - Annual Returns (2019 - 2026)
Returns include dividend reinvestment.
| Year | DOUG | IPHA |
|---|---|---|
| 2026 | -21.49% | -1.92% |
| 2025 | +45.40% | -6.42% |
| 2024 | -42.61% | -32.35% |
| 2023 | -23.85% | -17.65% |
| 2022 | -61.06% | -22.29% |
| 2021 | -5.19% | +5.80% |
| 2020 | N/A | -43.97% |
| 2019 | N/A | +6.45% |
DOUG vs IPHA Drawdown Comparison
The maximum drawdown for DOUG was -90.25%, occurring on Jun 17, 2024. This drawdown has not yet recovered.
The maximum drawdown for IPHA was -85.73%, occurring on Mar 20, 2026. This drawdown has not yet recovered.
The current DOUG drawdown is -83.23%. The current IPHA drawdown is -78.23%.
| Rank | DOUG | IPHA |
|---|---|---|
| #1 | -90.25% Dec 30, 2021 - Jun 17, 2024 | -85.73% May 11, 2020 - Mar 20, 2026 |
| #2 | N/A | -52.20% Feb 19, 2020 - May 11, 2020 |
| #3 | N/A | -12.06% Nov 11, 2019 - Jan 2, 2020 |
| #4 | N/A | -10.16% Jan 23, 2020 - Feb 13, 2020 |
| #5 | N/A | -9.99% Jan 8, 2020 - Jan 23, 2020 |
| #6 | N/A | -8.86% Oct 21, 2019 - Nov 5, 2019 |
| #7 | N/A | -4.27% Feb 13, 2020 - Feb 18, 2020 |
| #8 | N/A | -3.22% Nov 7, 2019 - Nov 11, 2019 |
| #9 | N/A | -1.78% Jan 2, 2020 - Jan 6, 2020 |
Correlation
Correlation between DOUG and IPHA is 0.71 which considered as a strong positive correlation - the stocks tend to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks